Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (PT862433) COMPOSICAO FARMACEUTICA ESPUMANTE TOPICA PARA O TRATAMENTO DE DERMATOSES INDUZIDAS POR PITYROSPORUM OVAL

Office : Portugal
Application Number: 96938270 Application Date: 07.11.1996
Publication Number: 862433 Publication Date: 31.01.2003
Publication Kind : E
IPC:
A61K 9/12
A61K 31/4418
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
12
Aerosols; Foams
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4418
having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine
CPC:
A61K 9/122
A61K 31/4418
Applicants: PF MEDICAMENT
Inventors: MROZ CHRISTIAN
LEVERD ELIE
LACROUX MARTINE
MROZ-COMBESSIS DANIELLE
BOUGARET JOEL
Priority Data: 9513202 08.11.1995 FR
Title: (PT) COMPOSICAO FARMACEUTICA ESPUMANTE TOPICA PARA O TRATAMENTO DE DERMATOSES INDUZIDAS POR PITYROSPORUM OVAL
Abstract:
(EN) A topical foamable pharmaceutical composition for treating skin diseases induced by oval Pityrosporum, containing (i) 0.1-10.0 wt %, preferably 2.1-6.0 wt % of ciclopirox or ciclopiroxolamine as the antifungal active principle, and (ii) 0.5-35.0 wt %, preferably 3-20 wt % and especially 5-15 wt % of a surfactant selected from alkylbetaines, alkylamidobetaines, cocamidoalkylamines and derivatives thereof, as well as mixtures thereof.
(FR) Composition pharmaceutique moussante à usage topique destinée au traitement des dermatoses induites par Pityrosporum ovale, caractérisée en ce qu'elle contient: (i) de 0,1 à 10,0 % en poids, de préférence 2,1 à 6,0 %, de ciclopirox ou de ciclopiroxolamine, et à titre de principe actif anti-fongique, (ii) 0,5 % à 35,0 % en poids, de préférence de 3 à 20 %, et plus particulièrement de 5 à 15 %, d'un tensio-actif choisi parmi les alkyl-bétaïnes, des alkyl-amidobétaïnes, les cocamidoalkylamines et leurs dérivés, ainsi que leurs mélanges.
Also published as:
EP0862433DE000069623641FR2740685WO/1997/017075